Inceptua
Inceptua – A Global Leader in Expanded Access Solutions
Inceptua is a recognized global leader in Early Access and Expanded Access Programs, supporting biotech and pharmaceutical companies in making investigational and unlicensed medicines available globally to patients with serious or life-threatening conditions – before regulatory approval or commercial launch.
Inceptua’s Early Access division delivers strategic guidance, program design, regulatory navigation, real-world data collection and full operational execution of programs world-wide. With unmatched experience and a proven global infrastructure, we ensure compliant, efficient, and patient-focused delivery of Early Access programs – tailored to meet the needs of both sponsors and healthcare professionals.
With over 25 years of experience serving life science companies of all sizes, Inceptua operates globally with offices across Europe, North America, and Asia. In addition to Early Access, Inceptua also provide global clinical trial supply services.
